Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sayako Akiyama"'
Autor:
Fumiko Ono, Sayako Akiyama, Akifumi Suzuki, Yoshinobu Ikeda, Akira Takahashi, Hitoshi Matsuoka, Masahiro Sasaki, Tomonori Okamura, Nariaki Yoshihara, The Akita study group
Publikováno v:
BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Care coordination between general practitioners (GPs) and cardiovascular specialists is expected to play a key role in establishing appropriate oral anticoagulant (OAC) treatment in atrial fibrillation (AF) patients. The aim of th
Externí odkaz:
https://doaj.org/article/e84ffae8c0e44d01bfc9a1d8dd91dbba
Autor:
Akifumi Suzuki, Tomonori Okamura, Masahiro Sasaki, Hitoshi Matsuoka, Yoshinobu Ikeda, Akira Takahashi, Sayako Akiyama, Fumiko Ono, Nariaki Yoshihara, Akita Study group
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0244240 (2020)
Cardio-embolic ischemic stroke caused by atrial fibrillation is more severe compared with other types of stroke, such as lacunar infarction and atherothrombotic infarction in patients without atrial fibrillation. Therefore, it is important to prevent
Externí odkaz:
https://doaj.org/article/29937ed41715470fb6f062402d79f874
Publikováno v:
International Journal of Women's Health
Background Dysmenorrhea affects approximately 80% of women in Japan and has a negative impact on health-related quality of life (HRQoL). Low-dose estrogen/progestin combined oral contraceptives have been shown to reduce the severity of dysmenorrhea s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c692ba6ab976449f512932f7fe0866c
https://doi.org/10.2147/ijwh.s238460
https://doi.org/10.2147/ijwh.s238460
Publikováno v:
Journal of Medical Economics. 23:252-261
Aims: This article aimed to examine the cost-effectiveness of rivaroxaban in comparison to warfarin for stroke prevention in Japanese patients with non-valvular atrial fibrillation (NVAF), from a public healthcare payer's perspective.Materials and me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::346ab7e03221db2d92b38931ef3ca8c2
https://doi.org/10.1080/13696998.2019.1688821
https://doi.org/10.1080/13696998.2019.1688821
Publikováno v:
Iryo To Shakai. 29:295-311
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e75adef781389446b581350e7419ee6
https://doi.org/10.4091/iken.2019.003
https://doi.org/10.4091/iken.2019.003
Autor:
Stefan J. Cano, Takeshi Yamashita, Jean-Baptiste Briere, Koichiro Kumagai, Yukihiro Koretsune, Gavin Dickie, Sayako Akiyama, Masahiro Yasaka, Benjamin Banderas, Emi Watanabe-Fujinuma, Shinichiro Uchiyama
Publikováno v:
Journal of Medical Economics. 22:798-805
Aims: The Anti-Clot Treatment Scale (ACTS) and Treatment Satisfaction Questionnaire for Medication version II (TSQM-II) are validated treatment satisfaction patient-reported outcome (PRO) i...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8553000b772cacee5b420432aa161154
https://doi.org/10.1080/13696998.2019.1609003
https://doi.org/10.1080/13696998.2019.1609003
Publikováno v:
International Journal of Women's Health
Mikio Momoeda,1 Sayako Akiyama,2 Shigetomo Yamamoto,3 Masami Kondo,4 Takeshi Fukai4 1Department of Integrated Women’s Health, St Luke’s International Hospital, Tokyo, Japan; 2Market Access, Bayer Yakuhin Ltd., Tokyo, Japan; 3Medical Affairs, Baye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e50d61cd8d5f0e17e1d40bbec61229
https://www.dovepress.com/burden-of-menstrual-pain-measured-by-heatmap-visualization-of-daily-pa-peer-reviewed-article-IJWH
https://www.dovepress.com/burden-of-menstrual-pain-measured-by-heatmap-visualization-of-daily-pa-peer-reviewed-article-IJWH
Autor:
Sayako Akiyama, Masahiro Yasaka, Emi Watanabe-Fujinuma, Yutaka Okayama, Yukihiro Koretsune, Shinichiro Uchiyama, Benjamin Banderas, Takeshi Yamashita, Stefan J. Cano, Koichiro Kumagai, Gavin Dickie, Jean-Baptiste Briere
Publikováno v:
Current Medical Research and Opinion. 34:2157-2164
Rivaroxaban has previously been shown to be as efficacious and safe as warfarin for the prevention of stroke in non-valvular atrial fibrillation (NVAF). Therefore, treatment satisfaction becomes an important consideration. Here we examine treatment s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::705fe48daaf95cd3fdd7060956277493
https://doi.org/10.1080/03007995.2018.1507315
https://doi.org/10.1080/03007995.2018.1507315
Publikováno v:
Patient preference and adherence
Sayako Akiyama,1 Amir Goren,2 Enrique Basurto,2 Tetsushi Komori,3 Tasuku Harada4 1Market Access, Bayer Yakuhin, Ltd., Tokyo, Japan; 2Health Outcomes Practice, Kantar Health, New York, NY, USA; 3Clinical Statistics, Bayer Yakuhin, Ltd., Osaka, Japan;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb22bad95e6facb532507e209603c3ef
http://europepmc.org/articles/PMC6124802
http://europepmc.org/articles/PMC6124802
Publikováno v:
Journal of medical economics. 21(9)
Heavy menstrual bleeding (HMB) is a highly prevalent condition, characterized by excessive menstrual blood loss and cramping, that interferes with activities of daily life. The aim of this study was to investigate treatment patterns in HMB in Japan,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7407ebd4f41744c930d1e02585f2b2bb
https://pubmed.ncbi.nlm.nih.gov/29770717
https://pubmed.ncbi.nlm.nih.gov/29770717